Fang L. Lv

500 Dongchuan Road
Shanghai, 200241, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 171 publications

Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

Journal: The New England journal of medicine

Published: July 08, 2026

Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence.

Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence.

Journal: Frontiers in pharmacology

Published: April 18, 2026

Non-phase change arylazopyrazole-containing alginate dressings with controlled heat release providing "hot spring" effect for wound healing.

Non-phase change arylazopyrazole-containing alginate dressings with controlled heat release providing "hot spring" effect for wound healing.

Journal: International journal of biological macromolecules

Published: March 15, 2026

Bioinformatics analysis and preliminary clinical validation of ITGA9 and NPTX2 as prognosis-related genes in acute myeloid leukemia.

Bioinformatics analysis and preliminary clinical validation of ITGA9 and NPTX2 as prognosis-related genes in acute myeloid leukemia.

Journal: Discover oncology

Published: February 25, 2026

Intensive blood pressure reduction but an increased risk of peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials.

Intensive blood pressure reduction but an increased risk of peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials.

Journal: Annals of medicine

Published: December 13, 2025

Multidimensional chromatographic fingerprint fusion with machine learning: Entropy-based feature evaluation for TCM quality marker discovery.

Multidimensional chromatographic fingerprint fusion with machine learning: Entropy-based feature evaluation for TCM quality marker discovery.

Journal: Talanta

Published: December 05, 2025

Antibody-Empowered Nanomedicine for Precise Biomedical Applications.

Antibody-Empowered Nanomedicine for Precise Biomedical Applications.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 27, 2025

Phase II trial of neoadjuvant camrelizumab and apatinib in resectable NSCLC: 3-year survival outcomes and dynamic circulating tumor DNA analyses.

Phase II trial of neoadjuvant camrelizumab and apatinib in resectable NSCLC: 3-year survival outcomes and dynamic circulating tumor DNA analyses.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 10, 2025

The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trials.

The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trials.

Journal: Therapeutic advances in musculoskeletal disease

Published: August 26, 2025

Anti-diabetic medications and cancer: links beyond glycemic and body weight control.

Anti-diabetic medications and cancer: links beyond glycemic and body weight control.

Journal: Precision clinical medicine

Published: July 29, 2025

Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional study.

Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional study.

Journal: Cardiovascular diabetology

Published: June 28, 2025

Weight Loss, Obesity Medication, and Risk of Obesity-Associated Cancer: A Meta-Analysis of Randomized Controlled Trials.

Weight Loss, Obesity Medication, and Risk of Obesity-Associated Cancer: A Meta-Analysis of Randomized Controlled Trials.

Journal: Obesity (Silver Spring, Md.)

Published: June 15, 2025

Showing 1-12 of 171

Last Updated: 09/26/2026